Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CureXcell in Chronic Venous Leg Ulcers
NCT02130310Phase 3Unknown
- Sponsor
- Macrocure Ltd.
- Start
- May 2014
- Primary completion
- May 2016
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of CureXcell in venous leg ulcer (VLU), sponsored by Macrocure Ltd.. Status: unknown.
02
Drugs
CureXcell
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT02130310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02130310.